|
Volumn 19, Issue 5, 2009, Pages 488-492
|
Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population
a a a a a a a a a a a b c d d e f g h i more.. |
Author keywords
DAS28 ESR; Etanercept; MTX; Non MTX nonbiologic DMARDs; Rheumatoid arthritis
|
Indexed keywords
ACTARIT;
BUCILLAMINE;
CYCLOSPORIN A;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
ETANERCEPT;
LEFLUNOMIDE;
METHOTREXATE;
MIZORIBINE;
PENICILLAMINE;
PREDNISOLONE;
SALAZOSULFAPYRIDINE;
TACROLIMUS;
TIOPRONIN;
ADULT;
ANGINA PECTORIS;
ARTICLE;
COLON PERFORATION;
COMBINATION CHEMOTHERAPY;
COMPRESSION FRACTURE;
CONTROLLED STUDY;
DISEASE ACTIVITY SCORE 28;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG TOLERABILITY;
DRUG USE;
DRUG WITHDRAWAL;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
HUMAN;
JAPANESE;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
OUTCOME ASSESSMENT;
POPULATION RESEARCH;
PREDICTION;
PRIORITY JOURNAL;
PRURITUS;
RASH;
REMISSION;
RESPIRATORY TRACT INFECTION;
RHEUMATOID ARTHRITIS;
SCORING SYSTEM;
SEPSIS;
SEX DIFFERENCE;
SIDE EFFECT;
SPINE DISEASE;
ADULT;
AGED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
BLOOD SEDIMENTATION;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
JAPAN;
MALE;
METHOTREXATE;
MIDDLE AGED;
PATIENT COMPLIANCE;
PREDICTIVE VALUE OF TESTS;
RECEPTORS, TUMOR NECROSIS FACTOR;
REGRESSION ANALYSIS;
REMISSION INDUCTION;
SEVERITY OF ILLNESS INDEX;
SEX FACTORS;
TREATMENT OUTCOME;
|
EID: 70350009796
PISSN: 14397595
EISSN: 14397609
Source Type: Journal
DOI: 10.1007/s10165-009-0187-8 Document Type: Article |
Times cited : (26)
|
References (8)
|